|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 31/282 | |||
| A61K 31/513 | |||
| A61K 31/519 | |||
| C07K 16/28 | |||
| C07K 16/22 | |||
| A61K 39/395 |
| (11) | Number of the document | 2855528 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729174.6 |
| Date of filing the European patent application | 2013-05-30 | |
| (97) | Date of publication of the European application | 2015-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/043452 |
| Date | 2013-05-30 |
| (87) | Number | WO 2013/181452 |
| Date | 2013-12-05 |
| (30) | Number | Date | Country code |
| 201261653861 P | 2012-05-31 | US |
| (72) |
MAECKER, Heather, US
IRVING, Bryan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, US |
| (54) | METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS |
| METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS |